243 related articles for article (PubMed ID: 31377937)
1. Prognostic relevance of ATM protein in uveal melanoma and its association with clinicopathological factors.
Jha J; Singh MK; Singh L; Pushker N; Bajaj MS; Sen S; Kashyap S
Int J Clin Oncol; 2019 Dec; 24(12):1526-1535. PubMed ID: 31377937
[TBL] [Abstract][Full Text] [Related]
2. DNA damage response proteins and its role in tumor progression of uveal melanoma with patient outcome.
Kashyap S; Jha J; Singh MK; Singh L; Sen S; Kaur J; Bajaj MS; Pushker N
Clin Transl Oncol; 2020 Sep; 22(9):1472-1480. PubMed ID: 32124242
[TBL] [Abstract][Full Text] [Related]
3. Association of TYRP1 with hypoxia and its correlation with patient outcome in uveal melanoma.
Jha J; Singh MK; Singh L; Pushker N; Lomi N; Meel R; Chosdol K; Sen S; Bakhshi S; Kashyap S
Clin Transl Oncol; 2021 Sep; 23(9):1874-1884. PubMed ID: 33811629
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of HERC2 protein and pink-eyed dilution protein in uveal melanoma.
Kashyap S; Singh MK; Jha J; Singh L; Pushker N; Sen S; Venkatesh P; Meel R; Lomi N
Hum Cell; 2020 Oct; 33(4):1264-1272. PubMed ID: 32686068
[TBL] [Abstract][Full Text] [Related]
5. Does NEMO/IKKγ protein have a role in determining prognostic significance in uveal melanoma?
Singh MK; Pushker N; Meel R; Chodsol K; Sen S; Bakhshi S; Singh L; Kashyap S
Clin Transl Oncol; 2018 Dec; 20(12):1592-1603. PubMed ID: 29796997
[TBL] [Abstract][Full Text] [Related]
6. ADAM 10 expression in primary uveal melanoma as prognostic factor for risk of metastasis.
Caltabiano R; Puzzo L; Barresi V; Ieni A; Loreto C; Musumeci G; Castrogiovanni P; Ragusa M; Foti P; Russo A; Longo A; Reibaldi M
Pathol Res Pract; 2016 Nov; 212(11):980-987. PubMed ID: 27546281
[TBL] [Abstract][Full Text] [Related]
7. Expression of BAP1 and ATM proteins: Association with AJCC tumor category in uveal melanoma.
Jha J; Singh MK; Singh L; Pushker N; Bajaj MS; Sen S; Kashyap S
Ann Diagn Pathol; 2020 Feb; 44():151432. PubMed ID: 31864162
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up.
Yue H; Qian J; Yuan Y; Zhang R; Bi Y; Meng F; Xuan Y
Curr Eye Res; 2017 May; 42(5):759-765. PubMed ID: 27911584
[TBL] [Abstract][Full Text] [Related]
9. Programmed cell death ligand-1 expression in tumor and immune cells is associated with better patient outcome and decreased tumor-infiltrating lymphocytes in uveal melanoma.
Zoroquiain P; Esposito E; Logan P; Aldrees S; Dias AB; Mansure JJ; Santapau D; Garcia C; Saornil MA; Belfort Neto R; Burnier MN
Mod Pathol; 2018 Aug; 31(8):1201-1210. PubMed ID: 29581543
[TBL] [Abstract][Full Text] [Related]
10. Intraocular tumor-associated lymphangiogenesis a novel prognostic factor for ciliary body melanomas with extraocular extension?
Heindl LM; Hofmann TN; Adler W; Knorr HL; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2010 Feb; 117(2):334-42. PubMed ID: 19892405
[TBL] [Abstract][Full Text] [Related]
11. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma.
Shah AA; Bourne TD; Murali R
Pathology; 2013 Dec; 45(7):651-6. PubMed ID: 24247622
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of Nuclear Phospho-ATM Expression in Melanoma.
Bhandaru M; Martinka M; McElwee KJ; Rotte A
PLoS One; 2015; 10(8):e0134678. PubMed ID: 26275218
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of p52 and RelB proteins in the metastatic and non-metastatic groups of uveal melanoma with patient outcome.
Singh MK; Singh L; Chosdol K; Pushker N; Saini N; Meel R; Bakhshi S; Sen S; Kashyap S
J Cancer Res Clin Oncol; 2019 Dec; 145(12):2969-2982. PubMed ID: 31612319
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of c-myc oncogene expression in uveal melanoma.
Chana JS; Cree IA; Foss AJ; Hungerford JL; Wilson GD
Melanoma Res; 1998 Apr; 8(2):139-44. PubMed ID: 9610866
[TBL] [Abstract][Full Text] [Related]
15. Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.
Blom DJ; Luyten GP; Mooy C; Kerkvliet S; Zwinderman AH; Jager MJ
Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1865-72. PubMed ID: 9286277
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of thrombospondin 2 inhibits metastasis through modulation of PI3K signaling pathway in uveal melanoma cell line M23.
Liu QH; Ma LS
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6230-6238. PubMed ID: 30338785
[TBL] [Abstract][Full Text] [Related]
17. JARID1B protein expression and prognostic implications in uveal melanoma.
Radberger P; Radberger A; Bykov VJ; Seregard S; Economou MA
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4442-9. PubMed ID: 22669717
[TBL] [Abstract][Full Text] [Related]
18. PRDX3 is associated with metastasis and poor survival in uveal melanoma.
Ramasamy P; Larkin AM; Linge A; Tiernan D; McAree F; Horgan N; Moriarty P; Beatty S; Murphy CC; Clynes M; Kennedy S; Meleady P
J Clin Pathol; 2020 Jul; 73(7):408-412. PubMed ID: 31771972
[TBL] [Abstract][Full Text] [Related]
19. Clinical Significance of Nucleoli Cytomorphology Assessment in Patients With Uveal Melanoma.
Berus T; Markiewicz A; Biecek P; Orłowska-Heitzman J; Hałoń A; Romanowska-Dixon B; Donizy P
Anticancer Res; 2020 Jun; 40(6):3505-3512. PubMed ID: 32487651
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological relevance of NFκB1/p50 nuclear immunoreactivity and its relationship with the inflammatory environment of uveal melanoma.
Singh MK; Singh L; Chosdol K; Pushker N; Meel R; Bakhshi S; Sen S; Kashyap S
Exp Mol Pathol; 2019 Dec; 111():104313. PubMed ID: 31533021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
